NCT06506513View on ClinicalTrials.gov

Targeting the Skeletal Muscle to Treat Metabolic Dysfunction-associated Steatotic Liver Disease

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

September 30, 2026

Conditions
Metabolic Dysfunction-associated Steatotic Liver Disease
Interventions
OTHER

High-intensity interval training

High-intensity interval training

OTHER

Moderate intensity exercise training

Moderate intensity exercise training

OTHER

Low intensity exercise training

Low intensity exercise training

Trial Locations (2)

1200

Cliniques universitaires Saint-Luc, Brussels

1348

Centre d'investigation clinique en nutrition, Louvain-la-Neuve

Sponsors

Collaborators (1)

Concerted Research Action
All Listed Sponsors
collaborator

Concerted Research Action

UNKNOWN

collaborator

Fonds National de la Recherche Scientifique

OTHER

lead

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

OTHER

NCT06506513 - Targeting the Skeletal Muscle to Treat Metabolic Dysfunction-associated Steatotic Liver Disease | Biotech Hunter | Biotech Hunter